Galaxy Surfactants Limited, a leading manufacturer of performance surfactants and specialty care products with over 215+ product grades used in the Home and Personal Care industry, has announced its financial results for the quarter, and nine months ended 31st December 2025.

The company reported a 27.6% growth in Total Revenue at Rs. 1,334.3 crore as compared to Rs. 1,045.7 crore in Q3 FY25. EBITDA during the quarter saw increase of 13.3% at Rs. 124.2 crore versus Rs. 109.6 crore. However, PAT in Q3 FY26 dropped by 8.8% to Rs. 59 crore as compared to Rs. 64.6 crore in Q3 FY25.

For the 9 month period ended December 31, 2025, Galaxy Surfactants posted Total Revenue of Rs. 3,955 crore (up 27.7%), EBITDA of Rs. 375.5 crore and PAT of Rs. 205 crore (down 10.5%).

During the quarter, India region witnessed mid single-digit growth and AMET region saw high double-digit growth.

Commenting on the performance, K. Natarajan, Managing Director, Galaxy Surfactants Limited, “The quarter gone by reflects a resilient performance in Q3FY26 despite multiple market headwinds. Consolidated volumes remained flat on YoY, with high single‑digit growth in Specialty Care Products offsetting softness in the Performance Surfactants segment.

EBITDA increased by 13% on YoY to Rs 124 crore, supported by stronger contributions from the Specialty segment in India and ROW region. Consequently, EBITDA/MT improved to Rs 20,156/MT reflecting a favorable product mix and disciplined cost management.

In India, domestic volumes grew in the mid‑single digit YoY, driven by strong traction from Non‑Tier‑1and D2C customers.

While the Performance segment declined due to ongoing reformulation at a key Tier‑1 account and temporary demand disruption following GST‑related inventory adjustments in October month, the Specialty segment delivered a robust 35% YoY volume growth, cushioning Tier‑1 softness and reinstating momentum across Tier‑2 and Tier‑3 accounts.

In the AMET region volumes declined in the high teens YoY, primarily due to heightened competitive intensity. Meanwhile ROW region continued to support portfolio resilience, delivering mid-single digit YoY volume growth, led by healthy demand across Latin America and Europe in both Performance and Specialty segments.

Prestige Specialty products from the company’s Tri‑K subsidiary continued to demonstrate strong momentum, enhancing the premium mix contribution. Although U.S. reciprocal tariffs weighed on India‑origin Specialty exports during the quarter the recent tariff rate reduction is expected to mitigate this impact going forward.

With India’s improving growth environment following GST reforms of AMET volumes in coming quarters, incremental benefits from the U.S.–India tariff revision, and continued premiumization of the Specialty portfolio, the Company remains confident of regaining growth momentum in the coming quarters.”